Antxrl Inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of the Antxrl protein, which is part of the anthrax toxin receptor family. Antxrl, also known as Anthrax Receptor-Like, plays a crucial role in cellular processes by mediating interactions with various extracellular ligands, including toxins and other signaling molecules. The protein is involved in facilitating the entry of certain toxins into cells, where they can exert their effects by disrupting cellular functions. Antxrl Inhibitors function by binding to key regions of the Antxrl protein, such as the extracellular ligand-binding domain or the transmembrane domain, thereby blocking its ability to interact with its ligands. This inhibition prevents the receptor from initiating the internalization of ligands, effectively disrupting the downstream signaling pathways that depend on these interactions.
The chemical design and properties of Antxrl Inhibitors are crucial for their specificity and effectiveness. These inhibitors are typically engineered to fit precisely within the ligand-binding site of the Antxrl protein, mimicking the natural ligands to competitively block their binding. The inhibitors may include hydrophobic regions that interact with the non-polar pockets of the receptor and polar or charged groups that form hydrogen bonds or electrostatic interactions with key amino acid residues in the binding site. Additionally, some inhibitors may target other critical regions of Antxrl, such as the transmembrane domain, to disrupt the receptor's conformation or its ability to anchor within the cell membrane. The solubility, stability, and bioavailability of these inhibitors are optimized to ensure that they can effectively reach and inhibit Antxrl in the cellular environment. The kinetics of binding, including how quickly the inhibitor associates with and dissociates from the Antxrl protein, are also important factors that influence the overall potency and duration of the inhibition. Understanding the interactions between Antxrl Inhibitors and their target protein provides valuable insights into the molecular mechanisms of ligand-receptor interactions and the broader biological processes mediated by the Antxrl protein. This understanding is essential for elucidating how Antxrl contributes to cellular responses to external signals and how its inhibition can alter these processes.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $94.00 $348.00 | 69 | |
Inhibits BMP signaling, which could influence cellular differentiation and growth. Inhibition of this pathway may reduce the functional activity of ANTXR like protein by modulating the cellular environment in which it operates. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
Inhibits Bcr-Abl tyrosine kinase and PDGF receptors, which could limit growth factor signaling that may be necessary for the functional activity of ANTXR like protein, thus inhibiting its activity. | ||||||